| Literature DB >> 33091066 |
Mukesh Thakur1, Abhishek Singh1,2, Bheem Dutt Joshi1, Avijit Ghosh1, Sujeet Kumar Singh1, Neha Singh3, Lalit Kumar Sharma1, Kailash Chandra1.
Abstract
The novel coronavirus 2019 (COVID-19) global pandemic has drastically affected the world economy, raised public anxiety, and placed a substantial psychological burden on the governments and healthcare professionals by affecting over 4.7 million people worldwide. As a preventive measure to minimise the risk of community transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in India, a nationwide lockdown was imposed initially for 21 days to limit the movement of 1.3 billion people. These restrictions continue in most areas, with a conditional relaxation occurring in a few Indian states. In an attempt to assess the emerging mutants of SARS-CoV-2 and determine their spread in India, we analysed 112 complete genomes of SARS-CoV-2 in a time-lapse manner. We found 72 distinct SARS-CoV-2 haplotypes, defined by 143 polymorphic sites and high haplotype diversity, suggesting that this virus possesses a high evolutionary potential. We also demonstrated that early introduction of SARS-CoV-2 into India was from China, Italy and Iran and observed signs of community spread of the virus following its rapid demographic expansion since its first outbreak in the country. Additionally, we identified 18 mutations in the SARS-CoV-2 spike glycoprotein and a few selected mutations showed to increase stability, binding affinity, and molecular flexibility in the overall tertiary structure of the protein that may facilitate interaction between the receptor binding domain (RBD) of spike protein and the human angiotensin-converting enzyme 2 (ACE2) receptor. The study provides a pragmatic view of haplotype-dependent spread of SARS-CoV-2 in India which could be important in tailoring the pharmacologic treatments to be more effective for those infected with the most common haplotypes. The findings based on the time-lapse sentinel surveillance of SARS-CoV-2 will aid in the development of a real-time practical framework to tackle the ongoing, fast-evolving epidemic challenges in the country.Entities:
Mesh:
Substances:
Year: 2020 PMID: 33091066 PMCID: PMC7580942 DOI: 10.1371/journal.pone.0241172
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Phylogenetic network analysis of complete SARS-CoV-2 genomes identified in India.
(a). Analysis based on 35 complete genomes available on the 21st of April 2020. (b). Analysis based on 53 complete genomes available on the 2nd of May 2020. (c) Analysis based on 112 complete genomes available on the 5th of May 2020 and retrieved from GISAID database.
Fig 2(a) Mismatch distribution curve of pairwise differences among SARS-CoV-2 genomes. (b) Demographic history of SARS-CoV-2 genomes estimated using Coalescent Bayesian Skyline plot. We applied a strict molecular clock and a substitution rate at 8×10−4/site/year to the MCMC run for 2.5×107 generations, sampled at every 1000 generations and discarded the first 2500 samples as burn-in. Other parameters were set as default values and results are visualized using TRACER v. 1.6. Bayesian skyline plot shows an overall increasing population size. The solid line represents the median estimates of Neμ (Ne = effective population size; μ = generation time) and the blue lines around median estimates indicate the 95% highest posterior density (HPD) estimate of the historic effective population size. The lines with nodes overlaid on BSP represented case histories of COVID-19 with data retrieved from MoHFW. The data was available in absolute number before transforming it to the log form to best fit with the axis also represented BSP results. The red line depicted number of deaths, green- number of recoveries, pink- number of active cases and blue represented total number of confirmed cases.
Fig 3Interaction pattern of wild and mutant residue with the surrounding residues of protein.
Wild-type and mutant residues are colored in light-green.